Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$51.7

Avg closing price
Price range

8 Cathie Wood Alnylam Pharmaceuticals Trades

The first Alnylam Pharmaceuticals trade was made in Q4 2016. Since then Cathie Wood bought shares three more times and sold shares on four occasions. The investor sold all their shares in Q3 2018 and doesn't own any shares in Alnylam Pharmaceuticals anymore.

Avg closing price
Price range
Sold -19.4 Thousand shares Q3 2018
Avg closing price $100.59
Price range $87.52 - $122.67
Increased shares by 74.2% (+8.25 Thousand shares) Q2 2018
Avg closing price $99.19
Price range $88.31 - $107.80
Increased shares by 429.6% (+9.01 Thousand shares) Q1 2018
Avg closing price $128.92
Price range $115.92 - $148.54
Sold 76.9% shares (-6.98 Thousand shares) Q4 2017
Avg closing price $125.65
Price range $114.49 - $139.98
Increased shares by 72.0% (+3.8 Thousand shares) Q3 2017
Avg closing price $85.36
Price range $72.53 - $118.27
Sold 15.2% shares (-948 shares) Q2 2017
Avg closing price $63.91
Price range $47.75 - $85.21
Sold 95.0% shares (-118 Thousand shares) Q1 2017
Avg closing price $46.22
Price range $36.88 - $59.71
New holding (+124 Thousand shares) Q4 2016
Avg closing price $41.87
Price range $31.41 - $70.30

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!